Weigao Intervention's Metal Drug-Eluting Stent System Receives Russian Medical Device Registration Certificate
Kinhely
Cardiovascular Interventional Device R&D and Production Company
Recently, the metal drug-eluting stent system independently developed by Kinhely Bio-Tech Co., Ltd., a subsidiary of Weigao Interventional Group, has successfully passed the review by relevant Russian regulatory authorities and officially obtained the Russian medical device registration certificate.
This significant milestone marks the international recognition of the company’s products in terms of quality and safety, laying a solid foundation for further expansion into the Russian and Eurasian markets.
Swipe left or right to view certificates
Weigao Interventional consistently adheres to innovation-driven development,
Strictly adhere to international quality standards.
The acquisition of this registration certificate,
not only demonstrates the company’s strength in systems and compliance,
It also demonstrates our commitment to serving global healthcare needs.
Future,
We will continue to promote the international application of our products,
To provide high-quality services to more medical institutions and patients.
